FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000136836> ?p ?o ?g. }

• W2000136836 endingPage "719" @default.
• W2000136836 startingPage "715" @default.
• W2000136836 abstract "Whether treatment with β blockers (BBs) is of benefit to patients with hypertrophic cardiomyopathy (HC) and provocable outflow obstruction (with none or with only mild heart failure symptoms) is largely unresolved. Thus, we prospectively studied 27 patients with HC (age 36 ± 15 years; 81% men) with New York Heart Association class I or II, without obstruction at rest, but with exercise-induced left ventricular outflow tract (LVOT) gradient of ≥30 mm Hg. Patients underwent exercise echocardiography at baseline and after treatment with nadolol (n = 18; 40 to 80 mg/day) or bisoprolol (n = 9; 5 to 10 mg/day), according to a prespecified protocol. Without the BBs, the postexercise LVOT gradient was 87 ± 29 mm Hg and >50 mm Hg in 25 patients (93%). After a 12 ± 4-month period of BB treatment, the postexercise LVOT gradient had decreased to 36 ± 22 mm Hg (p <0.001) and was virtually abolished (to 0 or <30 mm Hg) in 14 patients (52%), substantially blunted (≥20 mm Hg reduction) in 9 (33%), and unchanged in only 4 (15%). Severe postexercise obstruction (range 58 to 80 mm Hg) persisted in 6 patients (22% compared to 93% without BBs; p <0.001). Nonresponders (residual postexercise gradient of ≥30 mm Hg with BBs) were characterized by an increased body mass index (hazard ratio 2.03/1 kg/m2, 95% confidence interval 1.2 to 3.4; p <0.05). In conclusion, in patients with HC with mild or no symptoms, treatment with BBs can prevent the development of LVOT obstruction triggered by physiologic exercise. These findings provide a rationale for the novel strategy of early prophylactic pharmacologic treatment with standard, well-tolerated doses of BBs in physically active patients with provocable gradients, aimed at effective prevention of the hemodynamic burden associated with dynamic obstruction. Whether treatment with β blockers (BBs) is of benefit to patients with hypertrophic cardiomyopathy (HC) and provocable outflow obstruction (with none or with only mild heart failure symptoms) is largely unresolved. Thus, we prospectively studied 27 patients with HC (age 36 ± 15 years; 81% men) with New York Heart Association class I or II, without obstruction at rest, but with exercise-induced left ventricular outflow tract (LVOT) gradient of ≥30 mm Hg. Patients underwent exercise echocardiography at baseline and after treatment with nadolol (n = 18; 40 to 80 mg/day) or bisoprolol (n = 9; 5 to 10 mg/day), according to a prespecified protocol. Without the BBs, the postexercise LVOT gradient was 87 ± 29 mm Hg and >50 mm Hg in 25 patients (93%). After a 12 ± 4-month period of BB treatment, the postexercise LVOT gradient had decreased to 36 ± 22 mm Hg (p <0.001) and was virtually abolished (to 0 or <30 mm Hg) in 14 patients (52%), substantially blunted (≥20 mm Hg reduction) in 9 (33%), and unchanged in only 4 (15%). Severe postexercise obstruction (range 58 to 80 mm Hg) persisted in 6 patients (22% compared to 93% without BBs; p <0.001). Nonresponders (residual postexercise gradient of ≥30 mm Hg with BBs) were characterized by an increased body mass index (hazard ratio 2.03/1 kg/m2, 95% confidence interval 1.2 to 3.4; p <0.05). In conclusion, in patients with HC with mild or no symptoms, treatment with BBs can prevent the development of LVOT obstruction triggered by physiologic exercise. These findings provide a rationale for the novel strategy of early prophylactic pharmacologic treatment with standard, well-tolerated doses of BBs in physically active patients with provocable gradients, aimed at effective prevention of the hemodynamic burden associated with dynamic obstruction." @default.
• W2000136836 created "2016-06-24" @default.
• W2000136836 creator A5004834996 @default.
• W2000136836 creator A5029153489 @default.
• W2000136836 creator A5047329411 @default.
• W2000136836 creator A5048131213 @default.
• W2000136836 creator A5048771701 @default.
• W2000136836 creator A5052719563 @default.
• W2000136836 creator A5058059684 @default.
• W2000136836 creator A5059284373 @default.
• W2000136836 creator A5065690959 @default.
• W2000136836 creator A5073773875 @default.
• W2000136836 date "2012-09-01" @default.
• W2000136836 modified "2023-10-07" @default.
• W2000136836 title "β Blockers for Prevention of Exercise-Induced Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy" @default.
• W2000136836 cites W1501197722 @default.
• W2000136836 cites W1964639916 @default.
• W2000136836 cites W1966944760 @default.
• W2000136836 cites W2056559849 @default.
• W2000136836 cites W2063765763 @default.
• W2000136836 cites W2083348509 @default.
• W2000136836 cites W2087398999 @default.
• W2000136836 cites W2095002840 @default.
• W2000136836 cites W2095094855 @default.
• W2000136836 cites W2098395910 @default.
• W2000136836 cites W2109560166 @default.
• W2000136836 cites W2118891131 @default.
• W2000136836 cites W2146578470 @default.
• W2000136836 cites W2153151839 @default.
• W2000136836 cites W2469018802 @default.
• W2000136836 cites W25172371 @default.
• W2000136836 cites W3165153188 @default.
• W2000136836 doi "https://doi.org/10.1016/j.amjcard.2012.04.051" @default.
• W2000136836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22633205" @default.
• W2000136836 hasPublicationYear "2012" @default.
• W2000136836 type Work @default.
• W2000136836 sameAs 2000136836 @default.
• W2000136836 citedByCount "66" @default.
• W2000136836 countsByYear W20001368362012 @default.
• W2000136836 countsByYear W20001368362013 @default.
• W2000136836 countsByYear W20001368362014 @default.
• W2000136836 countsByYear W20001368362015 @default.
• W2000136836 countsByYear W20001368362016 @default.
• W2000136836 countsByYear W20001368362017 @default.
• W2000136836 countsByYear W20001368362018 @default.
• W2000136836 countsByYear W20001368362019 @default.
• W2000136836 countsByYear W20001368362020 @default.
• W2000136836 countsByYear W20001368362021 @default.
• W2000136836 countsByYear W20001368362022 @default.
• W2000136836 countsByYear W20001368362023 @default.
• W2000136836 crossrefType "journal-article" @default.
• W2000136836 hasAuthorship W2000136836A5004834996 @default.
• W2000136836 hasAuthorship W2000136836A5029153489 @default.
• W2000136836 hasAuthorship W2000136836A5047329411 @default.
• W2000136836 hasAuthorship W2000136836A5048131213 @default.
• W2000136836 hasAuthorship W2000136836A5048771701 @default.
• W2000136836 hasAuthorship W2000136836A5052719563 @default.
• W2000136836 hasAuthorship W2000136836A5058059684 @default.
• W2000136836 hasAuthorship W2000136836A5059284373 @default.
• W2000136836 hasAuthorship W2000136836A5065690959 @default.
• W2000136836 hasAuthorship W2000136836A5073773875 @default.
• W2000136836 hasBestOaLocation W20001368362 @default.
• W2000136836 hasConcept C126322002 @default.
• W2000136836 hasConcept C164705383 @default.
• W2000136836 hasConcept C207103383 @default.
• W2000136836 hasConcept C2777361368 @default.
• W2000136836 hasConcept C2778198053 @default.
• W2000136836 hasConcept C2778797674 @default.
• W2000136836 hasConcept C2780185194 @default.
• W2000136836 hasConcept C44249647 @default.
• W2000136836 hasConcept C71924100 @default.
• W2000136836 hasConcept C78085059 @default.
• W2000136836 hasConceptScore W2000136836C126322002 @default.
• W2000136836 hasConceptScore W2000136836C164705383 @default.
• W2000136836 hasConceptScore W2000136836C207103383 @default.
• W2000136836 hasConceptScore W2000136836C2777361368 @default.
• W2000136836 hasConceptScore W2000136836C2778198053 @default.
• W2000136836 hasConceptScore W2000136836C2778797674 @default.
• W2000136836 hasConceptScore W2000136836C2780185194 @default.
• W2000136836 hasConceptScore W2000136836C44249647 @default.
• W2000136836 hasConceptScore W2000136836C71924100 @default.
• W2000136836 hasConceptScore W2000136836C78085059 @default.
• W2000136836 hasIssue "5" @default.
• W2000136836 hasLocation W20001368361 @default.
• W2000136836 hasLocation W20001368362 @default.
• W2000136836 hasLocation W20001368363 @default.
• W2000136836 hasOpenAccess W2000136836 @default.
• W2000136836 hasPrimaryLocation W20001368361 @default.
• W2000136836 hasRelatedWork W2027691053 @default.
• W2000136836 hasRelatedWork W2034163884 @default.
• W2000136836 hasRelatedWork W2098118216 @default.
• W2000136836 hasRelatedWork W2162819327 @default.
• W2000136836 hasRelatedWork W2417419556 @default.
• W2000136836 hasRelatedWork W2779222010 @default.
• W2000136836 hasRelatedWork W3035006171 @default.
• W2000136836 hasRelatedWork W3095613549 @default.
• W2000136836 hasRelatedWork W4252140185 @default.
• W2000136836 hasRelatedWork W2035069710 @default.

• next